Back to Search
Start Over
Reversal of nonarteritic anterior ischemic optic neuropathy associated with coexisting primary antiphospholipid syndrome and Factor V Leiden mutation
- Source :
- American journal of ophthalmology. 131(5)
- Publication Year :
- 2001
-
Abstract
- PURPOSE: To report nonarteric anterior ischemic optic neuropathy (NAION) as an ocular manifestation in a woman with combined primary antiphospholipid syndrome and Factor V Leiden (FVL) mutation. METHODS: Case report of a middle-aged woman with hematological investigations confirming the diagnosis of both primary antiphospholipid syndrome and Factor V Leiden mutation, who presented with visual disturbance in her left eye. RESULTS: NAION was noted in her left eye. The patient was promptly treated with low molecular weight heparin, followed by warfarin, which resulted in the reversal of the ischemic optic neuropathy. CONCLUSIONS: Primary antiphospholipid syndrome and coexisting Factor V Leiden mutation should be considered in the differential diagnosis of NAION. Prompt treatment with anticoagulants can result in the reversal of the ischemic process.
- Subjects :
- medicine.medical_specialty
genetic structures
Eye disease
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction
Optic neuropathy
Internal medicine
medicine
Factor V Leiden
Humans
Point Mutation
Optic Neuropathy, Ischemic
cardiovascular diseases
Activated Protein C Resistance
Arteritis
business.industry
Warfarin
Anticoagulants
Factor V
Ischemic optic neuropathy
Heparin, Low-Molecular-Weight
Middle Aged
medicine.disease
Antiphospholipid Syndrome
Thrombosis
eye diseases
Surgery
Ophthalmology
Optic nerve
Cardiology
Anterior ischemic optic neuropathy
Female
business
medicine.drug
Subjects
Details
- ISSN :
- 00029394
- Volume :
- 131
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- American journal of ophthalmology
- Accession number :
- edsair.doi.dedup.....3b0293843952b5508eb824516ea00223